MATERIAL EVENT4886.TTSE

ASKA Pharmaceutical Holdings: change in parent company or specified subsidiary

Summary

ASKA Pharmaceutical Holdings CO., Ltd. filed an extraordinary report via EDINET on 2025-02-07 15:41 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100V7IG ↗ · PDL1.0 · Not investment advice